Pfizer

Manufacturing woes meant it lost out in race to market with its Covid vaccine

Pharma group is launching 19 drugs over the next 18 months to counteract a sharp fall in sales from pandemic highs

Vaccination recommended for young children with underlying health conditions

Roles will mostly be in the professional services and outsourcing leader's life sciences manufacturing division

Ireland has moved from a position when a lot of factors were in its favour to a more mixed picture

Results may allow pharma giant to compete with treatment approved in US last month

Appointment follows Laurence Flavin's decision to leave medical device company

Agency’s figures also point to partial displacement of trade following UK’s exit from EU

While scientists performed their magic, engineer Mike McDermott was charged with managing a fifteen-fold increase in the group’s vaccine manufacturing capacity

Business Today: the best news, analysis and comment from The Irish Times business desk

New facility to be built on Grange Castle site, adding 400-500 jobs

Sales drop 43% in third quarter as primary immunisation drives reach completion

In a staggering level of exposure 10 per cent of all tax revenue in Ireland is now coming from just 10 American corporations

US drug giant raises forecast for annual sales of its Covid-19 vaccine by $2bn on back of demand for Omicron boosters and plans for price rises

Capability to work with mRNA technology puts Dublin site in line for major additional investment

Seen & heard: Aer Lingus workers seek pay hike; Pfizer plans €1bn Dublin factory; Mike Ashley swoops on Asos

Pfizer, Apple and Amazon also feature high on the rankings

Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic

Top jab makers lose combined $10bn of market value amid fears over growing public apathy

Incoming Ipha president says industry expects to bring 30 new medicines to market in Ireland next year but warns on patent protection

Vaccines also include original version of virus

US biotech claims rival Covid vaccine makers infringed patents underpinning jabs

Just 647 Irish patients have used Paxlovid, taken by US president Joe Biden when he caught the virus last month

Antiviral treatment Paxlovid is being widely prescribed despite questions about its effectiveness

Pfizer encourages its people to think big and the results are visible in its ESG Strategy and innovative sustainability projects

US pharma group to pay €90.5m for 8% in deal that will boost joint Lyme disease programme

Shares rise sharply, surging by 14.5% in early session trading

President hails ‘monumental step forward’ in battle against virus but parents have been more cautious in inoculating children

Sanofi says trials point to potential of its vaccine booster candidate against main variants of concern

Interim results from its clinical trial showed the jab is safe and highly effective, company said

Paxlovid has been available in the State for more than a month

‘Transformational’ loan will allow green energy supplier meet fast-growing demand

Waning demand threatens efforts to produce vaccine locally so perhaps education is the priority

Biggest acquisition by US pharmaceutical giant in five years

With the virus rampant despite jabs, trials are underway to create intranasal vaccines

RepTrak study finds ‘Covid bounce’ in reputations has subsided

Pyongyang says it has kept its population Covid-free by sealing the country’s borders

Vaccine and Covid pill account for half of sales in first quarter of the year

Adoption of committee reports confirms extension intended to facilitate travel

Most lethal period of the pandemic was between January and February 2021